The UAE has cemented its reputation as a global leader in healthcare access, becoming only the second country in the world, after the United States to make Orforglipron (brand name: Foundayo) available to patients. The once-daily oral GLP-1 therapy, a needle-free breakthrough for weight management, is now stocked across the entire Life Pharmacy network, which spans more than 650 locations nationwide. The rapid approval reflects the UAE’s ambition to position itself at the forefront of medical innovation, consistently fast-tracking access to therapies that elsewhere remain years away from pharmacy shelves. That this rollout is being driven by Life Pharmacy, the country’s largest and most accessible pharmacy network, means the treatment reaches patients not just in major urban centres but across the full breadth of the UAE from day one. Orforglipron represents a significant departure from existing GLP-1 treatments, which require weekly injections.…